MariMed Insider Report: 89,860 RSUs Granted to CEO Jon Levine, Ownership Details

Rhea-AI Filing Summary

Jon R. Levine, President, CEO, Director and 10% owner of MariMed Inc. (MRMD), reported transactions on 09/15/2025. He received 89,860 restricted stock units (RSUs) that vest in part on 12/15/2025 and convert one-for-one into common shares. The filing shows 26,374 shares were withheld to satisfy tax obligations related to the RSU vesting, and 89,860 shares were recorded as acquired at $0 in connection with the RSU grant. Following these transactions, Levine directly beneficially owns 20,847,234 and indirectly owns 6,684,640 shares held by the Jon Levine Family Trust, totaling disclosed influence over the issuer.

Insights

Financial Analyst

TL;DR: Insider RSU grant increases executive alignment; share withholding covered taxes, overall ownership remains substantial.

The report documents an RSU award of 89,860 units granted May 9, 2025, with partial vesting on December 15, 2025. The immediate tax withholding of 26,374 shares reduced net shares delivered but does not change the disclosed level of control: direct beneficial ownership remains above 20.8 million shares while an additional 6.68 million are held indirectly in a family trust. For investors, this is a routine equity compensation event and signals continued executive stake in the company without any cash purchase or sale activity disclosed.

Corporate Governance Expert

TL;DR: Governance-wise this is a standard executive compensation filing showing retained ownership and use of a family trust.

The Form 4 shows standard disclosure practices: RSUs converting one-for-one to common stock, shares withheld to satisfy tax withholding, and a disclaimer of beneficial ownership for trust-held shares. The filing confirms the reporting person’s roles and indicates customary use of equity awards for alignment. There is no indication of unusual transfer, sale, or derivative activity beyond the RSU grant and withholding.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Levine Jon R

(Last) (First) (Middle)

C/O MARIMED INC.

10 OCEANA WAY

(Street)

NORWOOD, MA 02062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	09/15/2025		M		89,860	A	$0(1)	20,873,608	D
Common stock	09/15/2025		F		26,374(2)	D	$0.1374	20,847,234	D
Common stock								6,684,640	I	By the Jon Levine Family Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (RSU)	(1)	09/15/2025		M			89,860	(4)	(4)	Common Stock, par value $.001 per share	89,860	$0	89,859	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.

3. These shares are held in trust for the benefit of the Reporting Person's spouse and children. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

4. These RSUs were granted on May 9, 2025; the remaining RSUs will vest on December 15, 2025 in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Remarks:

	/s/ Jon R. Levine	09/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MRMD insider Jon R. Levine acquire on 09/15/2025?

He received 89,860 restricted stock units (RSUs) that convert one-for-one into common shares.

How many shares were withheld for taxes in the MRMD Form 4?

26,374 shares were withheld by the issuer to satisfy tax withholding obligations related to RSU vesting.

What is Jon Levine's total reported direct and indirect ownership in MRMD?

The filing shows 20,847,234 shares directly and 6,684,640 shares indirectly held in the Jon Levine Family Trust.

When will the remaining RSUs vest according to the filing?

The remaining RSUs are scheduled to vest on December 15, 2025 per the award agreement.

Were there any cash purchases or sales reported by the insider on this Form 4?

No cash purchases or sales were reported; the transactions reflect RSU vesting and tax withholding.